Vinorelbine

Welcome to Dwaey, specifically on Vinorelbine page.
This medicine contains important and useful components, as it consists of
Vinorelbine is available in the market in concentration.

Generic Name of Vinorelbine - Learn More

Vinorelbine

Vinorelbine Precaution - What You Need to Know

Before starting Vinorelbine, it is essential for patients to consult their healthcare provider, as several important precautions need to be considered:

- Bone Marrow Suppression: Vinorelbine can cause significant bone marrow suppression, leading to neutropenia, thrombocytopenia, and anemia. Regular blood count monitoring is necessary before and during treatment to detect bone marrow toxicity early.
- Liver Function: Vinorelbine is metabolized in the liver, so caution should be used in patients with liver impairment. Dose adjustments may be needed in patients with moderate hepatic dysfunction. Severe hepatic impairment is a contraindication for Vinorelbine use.
- Infection Risk: Because of its immunosuppressive effects, Vinorelbine may increase the risk of infections, particularly neutropenic infections. Patients should be closely monitored for signs of infection.
- Neuropathy: Vinorelbine may cause peripheral neuropathy, which can be dose-limiting. Patients should report any symptoms of tingling, numbness, or weakness in the limbs.
- Pregnancy and Breastfeeding: Vinorelbine is Category D for pregnancy, meaning it may cause harm to a developing fetus. It is contraindicated during pregnancy. Women should avoid breastfeeding while on Vinorelbine, as it may pass into breast milk.
- Elderly Patients: Elderly patients may be more sensitive to the side effects, particularly neuropathy and bone marrow suppression. Dosing adjustments or closer monitoring may be necessary in this group.

Vinorelbine Indication - Uses and Benefits

Vinorelbine is used in the treatment of various types of cancer, particularly non-small cell lung cancer (NSCLC) and breast cancer. Key indications include:

- Non-Small Cell Lung Cancer (NSCLC): Vinorelbine is commonly used for advanced or metastatic NSCLC as part of a combination therapy regimen with other chemotherapeutic agents.
- Breast Cancer: Vinorelbine is used in the treatment of metastatic breast cancer that is resistant to other forms of chemotherapy, particularly when other treatments have failed.
- Other Malignancies: Vinorelbine may be used for other solid tumors in specific clinical settings, as determined by the oncologist, often in combination with other chemotherapy drugs.

Vinorelbine Contraindications - Important Warnings

Vinorelbine should not be used in the following situations:

- Hypersensitivity: Contraindicated in patients with known hypersensitivity to Vinorelbine or its components.
- Severe Bone Marrow Suppression: Vinorelbine is contraindicated in patients with severe neutropenia (absolute neutrophil count < 1,000/mm³) or severe thrombocytopenia (platelet count < 50,000/mm³) due to the risk of exacerbating bone marrow suppression.
- Severe Hepatic Impairment: Vinorelbine is contraindicated in patients with severe liver dysfunction (bilirubin > 3 times the upper limit of normal or AST/ALT > 5 times the upper limit of normal).
- Pregnancy: It is contraindicated during pregnancy because of potential fetal harm, including teratogenicity.
- Breastfeeding: As Vinorelbine may be secreted in breast milk, it is contraindicated during breastfeeding.

Vinorelbine Side Effects - What to Expect

Vinorelbine, like many chemotherapeutic agents, can cause various side effects. These include:

- Common Side Effects:
- Nausea and Vomiting: These are common, particularly after the infusion, but they can be managed with antiemetics.
- Hair Loss (Alopecia): Hair loss is a frequent side effect during treatment, though it is typically temporary.
- Fatigue and Weakness: Generalized fatigue is a common side effect of chemotherapy.
- Constipation: Vinorelbine may cause constipation, which can be managed with laxatives or dietary changes.
- Peripheral Neuropathy: Symptoms such as tingling, numbness, or weakness in the extremities may occur.

- Serious Side Effects:
- Severe Neutropenia: A significant drop in neutrophils can leave patients vulnerable to infections, requiring dose adjustments or temporary cessation of treatment.
- Severe Thrombocytopenia: This results in a significantly reduced platelet count, increasing the risk of bleeding or bruising.
- Hepatotoxicity: Liver damage, indicated by jaundice or elevated liver enzymes, can occur, particularly in patients with pre-existing liver disease.
- Pulmonary Toxicity: Rare but serious side effects include interstitial lung disease and pulmonary fibrosis, which may be fatal if not detected early.

Vinorelbine Pregnancy Category ID - Safety Information

4

Vinorelbine Mode of Action - How It Works

Vinorelbine is a vinca alkaloid, which works by disrupting microtubule formation in cancer cells, essential for cell division. It binds to tubulin, a protein that makes up microtubules, and inhibits its polymerization into microtubules. This disruption prevents the proper formation of the mitotic spindle, a structure required for cell division. As a result, mitosis is arrested during the M phase of the cell cycle, leading to cell death. The drug is particularly effective against rapidly dividing cancer cells.

Vinorelbine Drug Interactions - What to Avoid

Vinorelbine has several potential interactions with other drugs that could affect its efficacy or safety. Notable interactions include:

- CYP450 Enzyme Inhibitors and Inducers: Vinorelbine is metabolized by CYP3A4. Drugs that inhibit CYP3A4 (e.g., ketoconazole, itraconazole) may increase Vinorelbine levels, potentially leading to more severe side effects, including neutropenia and neuropathy. Conversely, CYP3A4 inducers (e.g., rifampin, phenytoin) may reduce Vinorelbine's effectiveness by increasing its metabolism.
- Anticancer Drugs: When used in combination with other chemotherapeutic agents, particularly those that cause bone marrow suppression, the risk of neutropenia, thrombocytopenia, and anemia is increased. Close monitoring of blood counts is critical when combining chemotherapy drugs.
- Antibiotics: Macrolides (e.g., erythromycin) and fluoroquinolones (e.g., ciprofloxacin) may interact with Vinorelbine due to their effects on the CYP3A4 enzyme, increasing the risk of side effects.
- Vaccines: Live vaccines should generally be avoided in patients receiving Vinorelbine due to its immunosuppressive effect, which may reduce the efficacy of the vaccine and increase the risk of infection.

Vinorelbine Adult Dose - Recommended Dosage

The recommended dose of Vinorelbine for adults varies depending on the type of cancer being treated:

- Non-Small Cell Lung Cancer:
- Vinorelbine (intravenous): The typical dose is 25-30 mg/m² given once a week for maintenance therapy or in combination with other chemotherapy agents.
- Oral Vinorelbine: The usual starting dose is 60-80 mg/m² once a week.

- Metastatic Breast Cancer:
- Vinorelbine (intravenous): The typical dose is 25-30 mg/m² once a week.
- Oral Vinorelbine: If using the oral form, the dose is typically 60 mg/m² once a week.

The exact dose will depend on the patient's condition, overall health, and any other chemotherapy drugs being used.

Vinorelbine Child Dose - Dosage for Children

Vinorelbine is generally not recommended for pediatric patients due to a lack of sufficient safety and efficacy data. It is used primarily in adult oncology settings.

---

Always consult your healthcare provider before starting Vinorelbine to ensure it is appropriate for your cancer treatment and that the correct dosing is used based on your medical condition and overall health.

Vinorelbine Renal Dose - Dosage for Kidney Conditions

Vinorelbine is primarily metabolized by the liver, and its renal clearance is minimal. No dose adjustments are necessary for patients with renal impairment. However, close monitoring is recommended for patients with severe renal dysfunction, especially if they are also receiving other nephrotoxic drugs.